PRANA THERAPEUTICS, INC.
GAINESVILLE, FLORIDA

Prana Therapeutics was founded on a mission to develop combinatorial approaches to treating complex diseases. The company’s drug development program is based on pioneering research from the University of Florida. Prana Therapeutics has an exclusive worldwide license to the technology and its commercialization. Our lead compound, Epidiferphane, has demonstrated preclinical efficacy as a treatment to attenuate many of the negative side effects of chemotherapy (anemia, cytopenia, peripheral neuropathy, and chemofog), reduce inflammatory diseases (like rheumatoid arthritis) and helps slow the progression of tumor growth. "I am a Registered Dietitian and mother of two boys, ages 6 and 9. Together with a whole food diet, Epidiferphane helped me to boost my energy levels and alleviate my muscle aches and joint pain." "I am a 57-year-old strategist account manager and suffered a fall which required getting 2 plates and 8 screws in my ankle. While taking Procerna, it took exactly a month for me to see such a tremendous amount of improvement! My pain decreased as well as the swelling in my ankle, so now I’m able to accomplish day to day tasks again such as, lifting heavy objects and spending more time with friends and family without feeling like such a burden! Before Procerna, I tried, yoga, physical therapy and putting ice on the area. Nothing seemed to work as well as Procerna did. This product truly works!" We are an early stage biotechnology company developing Polymolecular Botanical Drugs for the healthcare industry. We are an early stage biotechnology company developing Polymolecular Botanical Drugs for the healthcare industry. Our Mission Prana Therapeutics is developing targeted therapeutics for prevention of the negative side effects of chemotherapy, management of rheumatoid arthritis and treatment of brain cancer.